Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bardoxolone methyl in CKD and type 2 diabetes
NCT01351675Phase 3Terminated
- Sponsor
- Biogen
- Start
- Jun 2011
- Primary completion
- Oct 2012
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 3 trial of bardoxolone methyl in chronic kidney disease (CKD), sponsored by Biogen. Started Jun 2011; status: terminated.
02
Drugs
bardoxolone methyl
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01351675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01351675.